Business segment information (Tables)
|
3 Months Ended |
Mar. 31, 2018 |
|---|
| Segment Reporting [Abstract] |
|
| Schedule of Net Sales by Reporting Segment |
The table below present net sales, which includes product sales and marketing service fees, by reporting segment:
|
|
|
Three Months Ended March 31, |
|
|
(U.S. Dollars, in thousands) |
|
2018 |
|
|
2017 |
|
|
Change |
|
|
BioStim |
|
$ |
46,163 |
|
|
$ |
44,539 |
|
|
|
3.6 |
% |
|
Extremity Fixation |
|
|
27,504 |
|
|
|
23,945 |
|
|
|
14.9 |
% |
|
Spine Fixation |
|
|
20,707 |
|
|
|
19,267 |
|
|
|
7.5 |
% |
|
Biologics |
|
|
14,335 |
|
|
|
14,987 |
|
|
|
-4.4 |
% |
|
Net sales |
|
$ |
108,709 |
|
|
$ |
102,738 |
|
|
|
5.8 |
% |
|
| Summary of Non-GAAP Net Margin by Reporting Segment |
The table below presents non-GAAP net margin by reporting segment:
|
|
|
Three Months Ended
March 31, |
|
|
(U.S. Dollars, in thousands) |
|
2018 |
|
|
2017 |
|
|
BioStim |
|
$ |
18,946 |
|
|
$ |
17,133 |
|
|
Extremity Fixation |
|
|
8,158 |
|
|
|
6,412 |
|
|
Spine Fixation |
|
|
1,261 |
|
|
|
2,007 |
|
|
Biologics |
|
|
6,080 |
|
|
|
6,171 |
|
|
Corporate |
|
|
(151 |
) |
|
|
(98 |
) |
|
Non-GAAP net margin |
|
$ |
34,294 |
|
|
$ |
31,625 |
|
|
General and administrative |
|
|
19,484 |
|
|
|
18,282 |
|
|
Research and development |
|
|
6,937 |
|
|
|
7,424 |
|
|
Operating income |
|
$ |
7,873 |
|
|
$ |
5,919 |
|
|
Interest income (expense), net |
|
|
(183 |
) |
|
|
45 |
|
|
Other income (expense), net |
|
|
2,912 |
|
|
|
(4,348 |
) |
|
Income before income taxes |
|
$ |
10,602 |
|
|
$ |
1,616 |
|
|
| Summary of Net Sales by Geographic Destination for Each Reporting Unit |
Geographical information
The table below present net sales by geographic destination for each reporting unit and for the consolidated Company:
|
|
|
Three Months Ended
March 31, |
|
|
(U.S. Dollars, in thousands) |
|
2018 |
|
|
2017 |
|
|
BioStim |
|
|
|
|
|
|
|
|
|
U.S. |
|
$ |
46,137 |
|
|
$ |
44,539 |
|
|
International |
|
|
26 |
|
|
|
— |
|
|
Total BioStim |
|
|
46,163 |
|
|
|
44,539 |
|
|
|
|
|
|
|
|
|
|
|
|
Extremity Fixation |
|
|
|
|
|
|
|
|
|
U.S. |
|
|
6,916 |
|
|
|
6,579 |
|
|
International |
|
|
20,588 |
|
|
|
17,366 |
|
|
Total Extremity Fixation |
|
|
27,504 |
|
|
|
23,945 |
|
|
|
|
|
|
|
|
|
|
|
|
Spine Fixation |
|
|
|
|
|
|
|
|
|
U.S. |
|
|
17,579 |
|
|
|
16,035 |
|
|
International |
|
|
3,128 |
|
|
|
3,232 |
|
|
Total Spine Fixation |
|
|
20,707 |
|
|
|
19,267 |
|
|
|
|
|
|
|
|
|
|
|
|
Biologics |
|
|
|
|
|
|
|
|
|
U.S. |
|
|
14,322 |
|
|
|
14,963 |
|
|
International |
|
|
13 |
|
|
|
24 |
|
|
Total Biologics |
|
|
14,335 |
|
|
|
14,987 |
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated |
|
|
|
|
|
|
|
|
|
U.S. |
|
|
84,954 |
|
|
|
82,116 |
|
|
International |
|
|
23,755 |
|
|
|
20,622 |
|
|
Net sales |
|
$ |
108,709 |
|
|
$ |
102,738 |
|
|